Aurora kinase inhibitors for inhibiting mitotic progression Grant US-11958855-B2 United States of America 16 Apr 2024
Solid pharmaceutical compositions and processes for their production Grant US-11786470-B2 United States of America 17 Oct 2023
Pyrimidine compounds and their pharmaceutical uses Application KR-20220151617-A Republic of Korea 15 Nov 2022
Solid pharmaceutical compositions and processes for their production Grant US-10888523-B2 United States of America 12 Jan 2021
Aurora kinase inhibitors for inhibiting mitotic progression Grant US-10836766-B2 United States of America 17 Nov 2020
Combination of aurora kinase inhibitors and anti-CD20 antibodies Application US-10391100-B2 United States of America 27 Aug 2019
METHODS FOR TREATING CONTRACTURED MUSCLE AND RELATED CULTURED CELLS Application WO-2019079259-A1 World Intellectual Property Organisation (WIPO) 25 Apr 2019
Methods of treating cancer using aurora kinase inhibitors Grant US-10213436-B2 United States of America 26 Feb 2019
LABELLED KINASES FOR DRUG DISCOVERY Application WO-2018167502-A1 World Intellectual Property Organisation (WIPO) 20 Sep 2018
Crystalline forms of sodium 4-{[9-chloro-7-(2-fluoro-6-methoxyphenyl)-5H-pyrimido [5,4-D][2… Application US-10017513-B2 United States of America 10 Jul 2018
Aurora kinase inhibitors for inhibiting mitotic progression Application US-9988384-B2 United States of America 05 Jun 2018
Aurora kinase inhibitors for inhibiting mitotic progression Grant US-9765076-B2 United States of America 19 Sep 2017
Combination of catalytic mTORC1/2 inhibitors and selective inhibitors of Aurora A kinase Grant US-9724354-B2 United States of America 08 Aug 2017
Protein kinase mutated aurora is sensitive to an inhibitor Application FR-3003871-A1 France 03 Oct 2014
INHIBITOR-SENSITIVE MUTATED AURORA A KINASE PROTEIN Application WO-2014155022-A1 World Intellectual Property Organisation (WIPO) 02 Oct 2014